Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Hahn, T; Barth, S; Graf, R; Engelmann, M; Beslagic, D; Reul, JM; Holsboer, F; Dohr, G; Desoye, G.
Placental glucose transporter expression is regulated by glucocorticoids.
J CLIN ENDOCRINOL METAB 1999 84: 1445-1452. Doi: 10.1210%2Fjc.84.4.1445 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Leading authors Med Uni Graz
Hahn Tom
Co-authors Med Uni Graz
Barth Sonja
Desoye Gernot
Dohr Gottfried
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Although glucocorticoids play important roles in development and fetal programming, they are widely used for treatment of a variety of diseases during pregnancy. In various tissues, glucocorticoids down-regulate glucose transport systems; however, their effects on glucose transporters in the placenta are unknown. In the present study, the glucose carrier proteins GLUT1 and GLUT3 were localized in the trophoblast and endothelium of the human, rat, and mouse placenta. Subsequently, it was investigated whether glucocorticoids affect messenger ribonucleic acid and protein expression of these molecules by Northern and Western blotting using 1) human term placental trophoblast cells cultured in the presence or absence of 0.5, 5, and 50 micromol/L triamcinolone; 2) placentas of rats that received a single i.p. dose of 0.38 mg/kg triamcinolone; and 3) placentas of transgenic mice bearing an antisense glucocorticoid receptor gene construct. In all of these systems, both glucose transporters were significantly down-regulated (P < 0.05), with the exception of increased GLUT3 messenger ribonucleic acid and protein levels in transgenic mice. The results demonstrate that triamcinolone is a potent regulator of placental GLUT1 and GLUT3 expression involving the glucocorticoid receptor. We speculate that impaired expression of placental glucose transporters after glucocorticoid administration might contribute to the adverse side-effects, the foremost of which is a growth-retarded fetus, of this treatment during pregnancy.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Blood Glucose - analysis
Body Weight - drug effects
Cells, Cultured - drug effects
Female - drug effects
Gene Expression Regulation - drug effects
Glucocorticoids - pharmacology
Glucose Transporter Type 1 - pharmacology
Glucose Transporter Type 3 - pharmacology
Humans - pharmacology
Mice - pharmacology
Monosaccharide Transport Proteins - analysis
Nerve Tissue Proteins - analysis
Placenta - chemistry
Pregnancy - chemistry
Rats - chemistry
Rats, Wistar - chemistry
Receptors, Glucocorticoid - physiology
Trophoblasts - metabolism

© Med Uni GrazImprint